U.S. flag

An official website of the United States government

NM_000483.5(APOC2):c.177C>G (p.Tyr59Ter) AND Familial apolipoprotein C-II deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 1, 1994
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000002696.2

Allele description [Variation Report for NM_000483.5(APOC2):c.177C>G (p.Tyr59Ter)]

NM_000483.5(APOC2):c.177C>G (p.Tyr59Ter)

Genes:
APOC4-APOC2:APOC4-APOC2 readthrough (NMD candidate) [Gene - HGNC]
APOC2:apolipoprotein C2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.32
Genomic location:
Preferred name:
NM_000483.5(APOC2):c.177C>G (p.Tyr59Ter)
Other names:
Y37*
HGVS:
  • NC_000019.10:g.44948822C>G
  • NG_008837.1:g.7837C>G
  • NM_000483.5:c.177C>GMANE SELECT
  • NP_000474.2:p.Tyr59Ter
  • NC_000019.9:g.45452079C>G
  • NM_000483.4:c.177C>G
  • NR_037932.1:n.1384C>G
Protein change:
Y59*; TYR37TER
Links:
OMIM: 608083.0008; dbSNP: rs120074111
NCBI 1000 Genomes Browser:
rs120074111
Molecular consequence:
  • NR_037932.1:n.1384C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000483.5:c.177C>G - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Familial apolipoprotein C-II deficiency
Synonyms:
APOC2 DEFICIENCY; C-II ANAPOLIPOPROTEINEMIA; HYPERLIPOPROTEINEMIA, TYPE IB; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008810; MedGen: C1720779; Orphanet: 444490; OMIM: 207750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000022854OMIM
no assertion criteria provided
Pathogenic
(Aug 1, 1994)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Identification of the mutation responsible for a case of plasmatic apolipoprotein CII deficiency (Apo CII-Bari).

Crecchio C, Capurso A, Pepe G.

Biochem Biophys Res Commun. 1990 May 16;168(3):1118-27.

PubMed [citation]
PMID:
1971748

Apolipoprotein CII-Padova (Tyr37-->stop) as a cause of chylomicronaemia in an Italian kindred from Siculiana.

Tuzgöl S, Bijvoet SM, Bruin T, Kastelein JJ, Hayden MR.

J Med Genet. 1994 Aug;31(8):622-6.

PubMed [citation]
PMID:
7815420
PMCID:
PMC1050024

Details of each submission

From OMIM, SCV000022854.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In an Italian family with 2 sibs with an abnormally high level of triglycerides and total deficiency of plasma C-II (207750), Crecchio et al. (1990) identified a C-G mutation in the third exon of the APOC2 gene, causing premature termination. Truncated at amino acid 36 of the mature form, the protein lost its functional domains, became inefficient, and could not be detected in plasma because of its high instability. The mutation destroyed an RsaI site.

Tuzgol et al. (1994) stated that the nonsense mutation in the APOC2 gene in apolipoprotein C-II(Bari) involves a 3002C-G transversion, resulting in the change of codon 37 from TAC (tyr) to TAG (stop). The codon involved is precisely the same as that in apolipoprotein C-II(Padova) (608083.0002) which has been reported in patients of Sicilian descent; the Bari variant was discovered in a patient of Sicilian descent. The nucleotides surrounding these mutations are GC rich and the presence of GC dinucleotides may serve as a potential hotspot for mutations.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022